These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9541692)

  • 1. CD44v6 is not a prognostic factor in primary breast cancer.
    Jansen RH; Joosten-Achjanie SR; Arends JW; Volovics A; Hupperets PS; Schouten HC; Hillen HF
    Ann Oncol; 1998 Jan; 9(1):109-11. PubMed ID: 9541692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study.
    Ma W; Deng Y; Zhou L
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study.
    Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM
    Tumori; 2010; 96(6):971-7. PubMed ID: 21388061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
    Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
    Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosol concentrations of CD44 isoforms in breast cancer tissue.
    Hefler L; Tempfer C; Haeusler G; Kucera E; Mayerhofer K; Zeillinger R; Reinthaller A; Kainz C
    Int J Cancer; 1998 Oct; 79(5):541-5. PubMed ID: 9761127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours.
    Imam H; Eriksson B; Oberg K
    Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 splice variants as prognostic markers in colorectal cancer.
    Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
    Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
    Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A
    Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
    Aaltomaa S; Lipponen P; Ala-Opas M; Kosma VM
    Eur Urol; 2001 Feb; 39(2):138-44. PubMed ID: 11223672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 is an independent prognostic factor in early-stage cervical cancer.
    Speiser P; Wanner C; Tempfer C; Mittelböck M; Hanzal E; Bancher-Todesca D; Gitsch G; Reinthaller A; Kainz C
    Int J Cancer; 1997 Apr; 74(2):185-8. PubMed ID: 9133453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study.
    Hefler LA; Concin N; Mincham D; Thompson J; Swarte NB; van Eijkeren MA; Sie-Go DM; Hammond I; McCartney AJ; Tempfer CB; Speiser P
    Cancer; 2002 Jan; 94(1):125-30. PubMed ID: 11815968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
    Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
    Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of osteopontin in breast cancer tissue and its relationship with p21ras and CD44V6 expression.
    Gao YL; Xing LQ; Ren TJ; Hou JF; Xue Q; Liu C; Han YM
    Eur J Gynaecol Oncol; 2016; 37(1):41-7. PubMed ID: 27048108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
    Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
    J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases.
    Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S
    J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
    Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.
    Charpin C; Garcia S; Bouvier C; Devictor B; Andrac L; Choux R; Lavaut MN; Allasia C
    Hum Pathol; 1997 Mar; 28(3):289-96. PubMed ID: 9042792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.